help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, R. K.
Right arrow Articles by Fidler, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, R. K.
Right arrow Articles by Fidler, I. J.

American Journal of Pathology, Vol 145, 365-374, Copyright © 1994 by American Society for Investigative Pathology


REGULAR ARTICLES

Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells

RK Singh, CD Bucana, M Gutman, D Fan, MR Wilson and IJ Fidler
Department of Cell Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

We investigated the influence of organ microenvironment on the angiogenic phenotype in human renal cell carcinoma (HRCC) cells. HRCC line SN12C was established in vitro from a surgical specimen, and metastatic line SN12PM6 was isolated from a lung metastasis produced by parental cells implanted into the kidney of nude mice. SN12C (low metastasis) and SN12PM6 (high metastasis) cells were injected into the kidney or subcutis of nude mice. The kidney tumors were highly vascularized (as revealed by immunohistochemistry using antibodies against factor VIII), and metastatic, whereas the subcutaneous tumors were not. The expression of mRNA for basic fibroblast growth factor (bFGF) in kidney tumors was 10 to 20 times that found in subcutaneous tumors. Similar data were obtained at the protein level by using fluorescence activated cell sorting, immunohistochemistry, and enzyme- linked immunosorbent assay. bFGF was detected in the urine of mice with tumors in the kidney but not subcutaneous tumors. The level of bFGF in the serum of mice with kidney tumors was two to three times that in mice with subcutaneous tumors. The changes in bFGF expression in the tumors was transient. Collectively, these data indicate that the organ microenvironment can influence the expression level of bFGF in HRCC.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
R. R. Langley and I. J. Fidler
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Endocr. Rev., May 1, 2007; 28(3): 297 - 321.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Esposito, E. Palescandolo, E. P. Spugnini, V. Montesarchio, A. De Luca, I. Cardillo, G. Cortese, A. Baldi, and A. Chirianni
Evaluation of Antitumoral Properties of the Protease Inhibitor Indinavir in a Murine Model of Hepatocarcinoma
Clin. Cancer Res., April 15, 2006; 12(8): 2634 - 2639.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Kim, Y.-W. Park, B. A. Schiff, D. D. Doan, Y. Yazici, S. A. Jasser, M. Younes, M. Mandal, B. N. Bekele, and J. N. Myers
An Orthotopic Model of Anaplastic Thyroid Carcinoma in Athymic Nude Mice
Clin. Cancer Res., March 1, 2005; 11(5): 1713 - 1721.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. Jussila and K. Alitalo
Vascular Growth Factors and Lymphangiogenesis
Physiol Rev, July 1, 2002; 82(3): 673 - 700.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Tedjarati, C. H. Baker, S. Apte, S. Huang, J. K. Wolf, J. J. Killion, and I. J. Fidler
Synergistic Therapy of Human Ovarian Carcinoma Implanted Orthotopically in Nude Mice by Optimal Biological Dose of Pegylated Interferon {alpha} Combined with Paclitaxel
Clin. Cancer Res., July 1, 2002; 8(7): 2413 - 2422.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. I. Izawa, P. Sweeney, P. Perrotte, D. Kedar, Z. Dong, J. W. Slaton, T. Karashima, K. Inoue, W. F. Benedict, and C. P. N. Dinney
Inhibition of Tumorigenicity and Metastasis of Human Bladder Cancer Growing in Athymic Mice by Interferon-{beta} Gene Therapy Results Partially from Various Antiangiogenic Effects Including Endothelial Cell Apoptosis
Clin. Cancer Res., April 1, 2002; 8(4): 1258 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Guo, L. Xu, S. Pan, R. A. Brekken, S.-T. Yang, G. B. Whitaker, M. Nagane, P. E. Thorpe, J. S. Rosenbaum, H.-J. Su Huang, et al.
Vascular Endothelial Growth Factor Isoforms Display Distinct Activities in Promoting Tumor Angiogenesis at Different Anatomic Sites
Cancer Res., December 1, 2001; 61(23): 8569 - 8577.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
I. J. Fidler
Angiogenic Heterogeneity: Regulation of Neoplastic Angiogenesis by the Organ Microenvironment
J Natl Cancer Inst, July 18, 2001; 93(14): 1040 - 1041.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. W. Slaton, K. Inoue, P. Perrotte, A. K. El-Naggar, D. A. Swanson, I. J. Fidler, and C. P. N. Dinney
Expression Levels of Genes that Regulate Metastasis and Angiogenesis Correlate with Advanced Pathological Stage of Renal Cell Carcinoma
Am. J. Pathol., February 1, 2001; 158(2): 735 - 743.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
I. J. Fidler
Regulation of Neoplastic Angiogenesis
J Natl Cancer Inst Monographs, December 1, 2000; 2000(28): 10 - 14.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Kuniyasu, W. Yasui, H. Shinohara, S. Yano, L. M. Ellis, M. R. Wilson, C. D. Bucana, T. Rikita, E. Tahara, and I. J. Fidler
Induction of Angiogenesis by Hyperplastic Colonic Mucosa Adjacent to Colon Cancer
Am. J. Pathol., November 1, 2000; 157(5): 1523 - 1535.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Yano, H. Shinohara, R. S. Herbst, H. Kuniyasu, C. D. Bucana, L. M. Ellis, D. W. Davis, D. J. McConkey, and I. J. Fidler
Expression of Vascular Endothelial Growth Factor Is Necessary but not Sufficient for Production and Growth of Brain Metastasis
Cancer Res., September 1, 2000; 60(17): 4959 - 4967.
[Abstract] [Full Text]


Home page
BloodHome page
F. Bertolini, L. Fusetti, P. Mancuso, A. Gobbi, C. Corsini, P. F. Ferrucci, G. Martinelli, and G. Pruneri
Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma
Blood, July 1, 2000; 96(1): 282 - 287.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Kuniyasu, P. Troncoso, D. Johnston, C. D. Bucana, E. Tahara, I. J. Fidler, and C. A. Pettaway
Relative Expression of Type IV Collagenase, E-cadherin, and Vascular Endothelial Growth Factor/Vascular Permeability Factor in Prostatectomy Specimens Distinguishes Organ-confined from Pathologically Advanced Prostate Cancers
Clin. Cancer Res., June 1, 2000; 6(6): 2295 - 2308.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Aziz, P. Hasleton, A. W. Hann, N. Yonan, A. Deiraniya, and I. V. Hutchinson
TRANSFORMING GROWTH FACTOR {beta} IN RELATION TO CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 700 - 708.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. S. Herbst, S. Yano, H. Kuniyasu, F. R. Khuri, C. D. Bucana, F. Guo, D. Liu, B. Kemp, J. J. Lee, W. K. Hong, et al.
Differential Expression of E-cadherin and Type IV Collagenase Genes Predicts Outcome in Patients with Stage I Non-Small Cell Lung Carcinoma
Clin. Cancer Res., March 1, 2000; 6(3): 790 - 797.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. S. Yoon, H. Eto, C.-m. Lin, H. Nakamura, T. M. Pawlik, S. U. Song, and K. K. Tanabe
Mouse Endostatin Inhibits the Formation of Lung and Liver Metastases
Cancer Res., December 1, 1999; 59(24): 6251 - 6256.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. W. Slaton, P. Perrotte, K. Inoue, C. P. N. Dinney, and I. J. Fidler
Interferon-{{alpha}}-mediated Down-Regulation of Angiogenesis-related Genes and Therapy of Bladder Cancer Are Dependent on Optimization of Biological Dose and Schedule
Clin. Cancer Res., October 1, 1999; 5(10): 2726 - 2734.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Rozera, D. Carlei, P. L. Lollini, C. De Giovanni, P. Musiani, E. Di Carlo, F. Belardelli, and M. Ferrantini
Interferon (IFN)-ß Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-{alpha} : Differential Effects on Tumorigenicity and Host Response
Am. J. Pathol., April 1, 1999; 154(4): 1211 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Dong, G. Greene, C. Pettaway, C. P. N. Dinney, I. Eue, W. Lu, C. D. Bucana, M. D. Balbay, D. Bielenberg, and I. J. Fidler
Suppression of Angiogenesis, Tumorigenicity, and Metastasis by Human Prostate Cancer Cells Engineered to Produce Interferon-{beta}
Cancer Res., February 1, 1999; 59(4): 872 - 879.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Kuniyasu, L. M. Ellis, D. B. Evans, J. L. Abbruzzese, C. J. Fenoglio, C. D. Bucana, K. R. Cleary, E. Tahara, and I. J. Fidler
Relative Expression of E-Cadherin and Type IV Collagenase Genes Predicts Disease Outcome in Patients with Resectable Pancreatic Carcinoma
Clin. Cancer Res., January 1, 1999; 5(1): 25 - 33.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.